Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
Lódi M, Priksz D, Fülöp GÁ, Bódi B, Gyöngyösi A, Nagy L, Kovács Á, Kertész AB, Kocsis J, Édes I, Csanádi Z, Czuriga I, Kisvárday Z, Juhász B, Lekli I, Bai P, Tóth A, Papp Z, Czuriga D.
Lódi M, et al. Among authors: fulop ga.
J Transl Med. 2019 Jul 19;17(1):229. doi: 10.1186/s12967-019-1978-0.
J Transl Med. 2019.
PMID: 31324258
Free PMC article.